Nasdaq-listed VivoPower secures 211M XRP at 86% discount alongside $100M Ripple share purchase in landmark deal.

Presented positive 6-month clinical results of ongoing type 1 diabetes study showing that hypoimmune-modified pancreatic islet cells transplanted without immunosuppression overcome immune recognition, ...